Cdk11B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| CDK11B | |
|---|---|
| Gene Symbol | CDK11B |
| Full Name | Cyclin Dependent Kinase 11B |
| Chromosome | 1p36.21 |
| NCBI Gene ID | 984 |
| OMIM | 300303 |
| Ensembl ID | ENSG00000167257 |
| UniProt ID | Q9UQ88 |
| Associated Diseases | Cancer, Neurodevelopmental Disorders, Neurodegeneration |
Cyclin-Dependent Kinase 11B (CDK11B) is a member of the CDK (cyclin-dependent kinase) family, a group of serine/threonine kinases that regulate the cell cycle and various cellular processes. CDK11B is encoded by the CDK11A gene locus through alternative splicing and is widely expressed in human tissues, including the brain. CDK11B plays essential roles in RNA splicing, cell cycle progression, transcription regulation, and has been implicated in neuronal development and synaptic function. Dysregulated CDK11B expression and activity contribute to cancer progression and may play roles in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS).
CDK11B functions in cell cycle control:
CDK11B activity is required for:
CDK11B is a key regulator of RNA metabolism:
The CDK11B-cyclin L complex localizes to nuclear speckles and regulates:
In neurons, CDK11B is involved in:
CDK11B localizes to:
CDK11B affects transcription through:
CDK11B overexpression is common in many cancers:
Oncogenic roles include:
CDK11B promotes cancer through:
CDK11B mutations may contribute to:
Alzheimer's Disease:
Parkinson's Disease:
Amyotrophic Lateral Sclerosis:
Huntington's Disease:
CDK11B is ubiquitously expressed with highest levels in:
In the brain, CDK11B is expressed in:
Expression is developmentally regulated with high expression during brain development.
CDK11B is a potential therapeutic target:
Modulating CDK11B in neurodegeneration:
The study of Cdk11B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.